ILMN:Illumina Inc Snapshot | Charting | News | Options
$144.18 NASDAQ 9:15a ET
October 31 '24 		Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human ... PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on ILMN
    No News Available
    Illumina introduces the MiSeq i100 Series: its simplest, fastest benc...
    12:10p ET October 9 '24 PR Newswire
    Illumina to Announce Third Quarter 2024 Financial Results on Monday, ...
    4:05p ET October 7 '24 PR Newswire
    Charles Dadswell to step down as General Counsel, Illumina initiates ...
    5:47p ET October 3 '24 PR Newswire
    Illumina and LGC Biosearch Technologies join forces to drive genomic ...
    2:01a ET September 19 '24 PR Newswire
    European Court of Justice rules in favor of Illumina in jurisdictiona...
    4:00a ET September 3 '24 PR Newswire
    Results of GRAIL's Galleri(R) Multi-Cancer Early Detection Blood Test...
    4:17p ET August 29 '24 PR Newswire
    FDA approves Illumina cancer biomarker test with two companion diagno...
    9:15a ET August 27 '24 PR Newswire
    Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, ...
    6:02a ET August 23 '24 News Direct
    Illumina announces strategy to accelerate value creation
    11:00a ET August 13 '24 PR Newswire
    Illumina Reports Financial Results for Second Quarter of Fiscal Year ...
    4:05p ET August 6 '24 PR Newswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.